199 related articles for article (PubMed ID: 9551842)
1. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
[TBL] [Abstract][Full Text] [Related]
2. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
[TBL] [Abstract][Full Text] [Related]
3. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
[TBL] [Abstract][Full Text] [Related]
4. Tiagabine (gabitril) experience in children.
Pellock JM
Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
[TBL] [Abstract][Full Text] [Related]
5. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.
Richens A; Chadwick DW; Duncan JS; Dam M; Gram L; Mikkelsen M; Morrow J; Mengel H; Shu V; McKelvy JF
Epilepsy Res; 1995 May; 21(1):37-42. PubMed ID: 7641674
[TBL] [Abstract][Full Text] [Related]
7. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.
Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V
Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
9. Tiagabine monotherapy in the treatment of partial epilepsy.
Schachter SC
Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
[TBL] [Abstract][Full Text] [Related]
10. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
[TBL] [Abstract][Full Text] [Related]
12. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
Loiseau P
Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
[TBL] [Abstract][Full Text] [Related]
13. Tiagabine add-on for drug-resistant partial epilepsy.
Pulman J; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD001908. PubMed ID: 24500879
[TBL] [Abstract][Full Text] [Related]
14. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
Chmielewska B; Stelmasiak Z
Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
[TBL] [Abstract][Full Text] [Related]
15. Tiagabine add-on for drug-resistant partial epilepsy.
Pereira J; Marson AG; Hutton JL
Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
[TBL] [Abstract][Full Text] [Related]
16. Tiagabine add-on for drug-resistant partial epilepsy.
Pulman J; Marson AG; Hutton JL
Cochrane Database Syst Rev; 2012 May; 5(5):CD001908. PubMed ID: 22592677
[TBL] [Abstract][Full Text] [Related]
17. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
Shorvon SD; Löwenthal A; Janz D; Bielen E; Loiseau P
Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
[TBL] [Abstract][Full Text] [Related]
19. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological effects of tiagabine, a potential new antiepileptic drug.
Sveinbjornsdottir S; Sander JW; Patsalos PN; Upton D; Thompson PJ; Duncan JS
Seizure; 1994 Mar; 3(1):29-35. PubMed ID: 8044451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
